Pressemeddelelse

Coala Life receives subscription commitments and declarations of intent to subscribe through exercise of warrants amounting to approximately SEK 5.6 million

Coala-Life Group AB (publ) (“Coala Life” or the “Company”) has received subscription commitments and declarations of intent to subscribe through exercise of warrants of series TO 1 (the “Warrants”). The subscription commitments and declarations of intent to subscribe amount to approximately SEK 5.6 million in total, corresponding to approximately 40.4 per cent of the Warrants.

Coala Life issued, in conjunction with a rights issue of units during the first quarter of 2023, a total of 164,979,967 Warrants. The exercise period for the Warrants runs from September 11, 2023, until and including September 22, 2023. Three (3) Warrants entitle the holder to subscribe for one (1) new share in the Company. The subscription price per share that is subscribed for through the exercise of Warrants has been set to SEK 0.25. Upon exercise of all Warrants, Coala Life will receive approximately SEK 13.7 million before issue costs.

Coala Life has received subscription commitments and declarations of intent to subscribe from current shareholders holding Warrants. The subscription commitments and declarations of intent to subscribe amount to approximately SEK 5.6 million in total, corresponding to approximately 40.4 per cent of the Warrants. The subscription commitments amount to approximately SEK 4.7 million, corresponding to approximately 34.1 per cent of the Warrants and the declarations of intent to subscribe amount to approximately SEK 0.9 million, corresponding to approximately 6.3 per cent of the Warrants. The subscription commitments are not secured by bank guarantees, blocked funds, pledges, or similar arrangements.

Advisors
Redeye AB är finansiell rådgivare, Setterwalls Advokatbyrå AB är legal rådgivare och Nordic Issuing agerar emissionsinstitut i samband med utnyttjandet av Teckningsoptionerna.

IMPORTANT INFORMATION
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, warrants or other securities in the Company. An invitation to the persons concerned to subscribe for units consisting of shares in the Company and Warrants has only been made through the prospectus and supplementary prospectus approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and published on February 6, 2023 and February 14, 2023, respectively.

About us

Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease.
For more information see www.coalalife.com